Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.
Earnings
see more| Q1 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-05-21 | ||||||
| REV | |||||||
| Q4 2020 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.450 | ||||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PRLD | Prelude Therapeutics | 1.99% | 2B |
Prelude Therapeutics Company Questions & Answers
Q
How do I buy Prelude Therapeutics (PRLD) stock?
A
You can purchase shares of Prelude Therapeutics (NASDAQ: PRLD) through any online brokerage.
Q
Who are Prelude Therapeutics's (PRLD) main competitors?
A
There are no as such competitors for Prelude Therapeutics.
Q
What is the target price for Prelude Therapeutics?
A
The latest price target for Prelude Therapeutics (NASDAQ: PRLD) was reported by HC Wainwright & Co. on 2021-04-26. The analyst firm set a price target for 62.00 expecting PRLD to rise to within 12 months (a possible 49.00% upside). 7 analyst firms have reported ratings in the last year.
Q
How much is Prelude Therapeutics (PRLD) stock ?
A
The stock price for Prelude Therapeutics (NASDAQ: PRLD) is $41.61 last updated Fri May 07 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
Q
When is the next Prelude Therapeutics (PRLD) dividend?
A
There are no upcoming dividends for Prelude Therapeutics.
Q
When is Prelude Therapeutics (NASDAQ:PRLD) reporting earnings?
A
Prelude Therapeutics’s Q2 earnings are confirmed after-market from now on July 28, 2021.
Q
When is the upcoming split for PRLD?
A
There is no upcoming split for Prelude Therapeutics.